Business
INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In NIO, CORT, HCSG or FCHS To Contact The Firm
INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In NIO, CORT, HCSG or FCHS To Contact The Firm.
About this update from First Choice Healthcare Solutions, Inc.
[{"type":"text","content":"\nNEW YORK, May 12, 2019 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, encourages investors in the following companies to contact the firm:\n Company: NIO, Inc. (NYSE:NIO)Lead Plaintiff Deadline: May 13, 2019Class Period: September 12, 2018 and March 5, 2019Contact Us: www.faruqilaw.com/NIO The case, Tan v. NIO Inc. et al, Docket No. 19-cv-01424, has been filed in the United States District Court for the Eastern District of New York against the Company and certain of its officers. The lawsuit focuses on whether the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) NIO would not be building its own manufacturing plant and would instead continue to rely on JAC Auto to manufacture its vehicles; (2) reductions in government subsidies for electric cars would materially impact NIO’s sales; and (3) as a result, Defendants’ statements about NIO’s business, operations, and prospects were materially false and misleading at all relevant times.The case has been assigned to Judge Nicholas G. Garaufis. Company: Corcept Therapeutics Incorporated (NASDAQ:CORT)Lead Plaintiff Deadline: May 13, 2019Class Period: August 2, 2017 and February 5, 2019Contact Us: www.faruqilaw.com/CORT The case, Melucci v. Corcept Therapeutics Incorporated et al., No. 19-cv-01372, has been filed in the United States District Court for the Northern District of California against the Company and certain of its officers. The lawsuit focuses on whether the Company and its executives violated federal securities laws by failing to disclose to investors: (1) that the Company had improperly paid doctors to promote its drug Korlym; (2) that the Company aggressively promoted Korlym for off-label uses; (3) that the Company’s sole specialty pharmacy was a related party; (4) that the Company artificially inflated its revenue and sales using illicit sales practices through a related party; and (5) that such practices are reasonably likely to lead to regulatory scrutiny. The case has been assigned to Judge Lucy H. Koh. Company: Healthcare Services Group, Inc. (NASDAQ:HCSG)Lead Plaintiff Deadline: May 21, 2019Class Period: April 11, 2017 and March 4, 2019Contact Us: www.faruqilaw.com/HCSG The case, Koch v. Healthcare Services Group...